278 related articles for article (PubMed ID: 17167438)
1. Agency set up to tackle bioterror.
Wadman M
Nature; 2006 Dec; 444(7121):796-7. PubMed ID: 17167438
[No Abstract] [Full Text] [Related]
2. Biodefense. Critics question proposed countermeasures agency.
Kaiser J
Science; 2005 Nov; 310(5749):755. PubMed ID: 16272086
[No Abstract] [Full Text] [Related]
3. Bioterrorism. BioShield is slow to build U.S. defenses against bioweapons.
Kaiser J
Science; 2006 Jul; 313(5783):28-9. PubMed ID: 16825542
[No Abstract] [Full Text] [Related]
4. Throwing money at biodefense.
DeFrancesco L
Nat Biotechnol; 2004 Apr; 22(4):375-8. PubMed ID: 15060542
[No Abstract] [Full Text] [Related]
5. Biodefense: 10 years after. Reinventing Project BioShield.
Cohen J
Science; 2011 Sep; 333(6047):1216-8. PubMed ID: 21885752
[No Abstract] [Full Text] [Related]
6. Managing science. House votes to kill grants, limit travel to meetings.
Kaiser J
Science; 2004 Sep; 305(5691):1688. PubMed ID: 15375232
[No Abstract] [Full Text] [Related]
7. Homeland security plan sparks fears for fight against bioterror.
Brumfiel G
Nature; 2002 Jun; 417(6890):675. PubMed ID: 12066141
[No Abstract] [Full Text] [Related]
8. Bioterrorism. Congress adopts tough rules for labs.
Malakoff D
Science; 2002 May; 296(5573):1585-7. PubMed ID: 12040151
[No Abstract] [Full Text] [Related]
9. Health secretary under attack over centralization plan.
Check E
Nature; 2002 Jan; 415(6869):250. PubMed ID: 11796970
[No Abstract] [Full Text] [Related]
10. Biomedical research. First house vote good for NIH budget.
Malakoff D
Science; 2001 Oct; 294(5541):279-81. PubMed ID: 11598273
[No Abstract] [Full Text] [Related]
11. Biodefence on the research agenda.
Fauci AS
Nature; 2003 Feb; 421(6925):787. PubMed ID: 12594484
[No Abstract] [Full Text] [Related]
12. Protest letter accuses health agency of biodefence bias.
Check E
Nature; 2005 Mar; 434(7029):7. PubMed ID: 15744263
[No Abstract] [Full Text] [Related]
13. Cost/success projections for US biodefense countermeasure development.
Matheny J; Mair M; Smith B
Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
[No Abstract] [Full Text] [Related]
14. An overview of the HHS budget proposal.
Rubin RJ
J Med Pract Manage; 2005; 20(6):288-9. PubMed ID: 16149203
[No Abstract] [Full Text] [Related]
15. The Orphan Products Board of the Department of Health & Human Services.
Crooks GM
Prog Clin Biol Res; 1985; 197():19-23. PubMed ID: 4070294
[No Abstract] [Full Text] [Related]
16. Biodefence takes its toll.
Nature; 2003 Jun; 423(6940):571. PubMed ID: 12789296
[No Abstract] [Full Text] [Related]
17. Biodefence research.
Russo E
Nature; 2002 Apr; 416(6882):4-5. PubMed ID: 11961508
[No Abstract] [Full Text] [Related]
18. Teleconferences help educate on bioterrorism.
Hosp Peer Rev; 2002 Apr; 27(4):55-7. PubMed ID: 11951725
[No Abstract] [Full Text] [Related]
19. Biodefense. House passes plan for drug, vaccine R&D.
Kaiser J
Science; 2006 Oct; 314(5796):39. PubMed ID: 17023625
[No Abstract] [Full Text] [Related]
20. Unified agenda of federal regulatory and deregulatory actions--HHS. Semiannual regulatory agenda.
Fed Regist; 1998 Nov; 63(216 Pt 2):61680-786. PubMed ID: 10187396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
